The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Geno...
24 Enero 2011 - 10:03AM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
Genoptix, Inc. (“Genoptix” or the “Company”) (Nasdaq: GXDX) for
possible breaches of fiduciary duty and other violations of state
law in connection with the sale of the Company to Novartis. Under
the terms of the transaction, Genoptix shareholders will receive
$25.00 cash for each share of Genoptix common stock they own, for a
total transaction value of approximately $470 million.
Click here to learn how to join the action:
http://www.zlk.com/genoptix-gxdx.html, or call: 877-363-5972.
The investigation concerns whether the Genoptix Board of
Directors breached their fiduciary duties to Genoptix stockholders
by failing to adequately shop the Company before entering into this
transaction and whether Novartis is underpaying for Genoptix
shares, thus unlawfully harming Genoptix stockholders. In
particular, at least one analyst set a price target of $28.00 per
share and Genoptix stock traded as high as $38.79 per share as
recently as April 30, 2010.
If you own common stock in Genoptix and wish to obtain
additional information, please contact Joseph E. Levi, Esq. either
via email at jlevi@zlk.com or by telephone at (212) 363-7500,
toll-free: (877) 363-5972, or visit
http://www.zlk.com/genoptix-gxdx.html.
Levi & Korsinsky has expertise in prosecuting investor
securities litigation and extensive experience in actions involving
financial fraud and represents investors throughout the nation,
concentrating its practice in securities and shareholder
litigation. The attorneys at Levi & Korsinsky have been
appointed by numerous courts throughout the country to serve as
lead counsel on behalf of shareholders in major litigations
involving mergers and acquisitions. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
Genoptix, Inc. (MM) (NASDAQ:GXDX)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Genoptix, Inc. (MM) (NASDAQ:GXDX)
Gráfica de Acción Histórica
De May 2023 a May 2024
Real-Time news about Genoptix, Inc. (MM) (NASDAQ): 0 recent articles
Más de Levi & Korsinsky, LLP Artículos de Noticias